Baseline Corticosteroid Use and Corticosteroid-Free Clinical Remission in Crohn’s Disease Patients Treated With Certolizumab Pegol in the PRECiSE 2 Trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.